{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:22:37Z","timestamp":1792815757029,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK 07760"],"award-info":[{"award-number":["DK 07760"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010656","name":"Canadian Celiac Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000149","name":"Canadian Association of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012854","name":"Children's Hospital Research Institute of Manitoba","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012854","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10620-017-4666-z","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T08:28:35Z","timestamp":1499416115000},"page":"2449-2454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Symptoms of Functional Intestinal Disorders Are Common in Patients with Celiac Disease Following Transition to a Gluten-Free Diet"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3615-1666","authenticated-orcid":false,"given":"Jocelyn A.","family":"Silvester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rigaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciar\u00e1n P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Duerksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"key":"4666_CR1","doi-asserted-by":"crossref","unstructured":"Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013; 108:656\u2013676; quiz 677.","DOI":"10.1038\/ajg.2013.79"},{"key":"4666_CR2","unstructured":"Drossman DA, Corazziari E, Delvaux M, et al. Rome III diagnostic questionnaire for the adult functional GI disorders (including alarm questions) and scoring algorithm. In: Rome III: The Functional Gastrointestinal Disorders. 3rd ed. Degnon Associates. 2006; 917\u2013951."},{"key":"4666_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ajg.2016.466","volume":"112","author":"AJ Irvine","year":"2017","unstructured":"Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2017;112:65\u201376.","journal-title":"Am J Gastroenterol"},{"key":"4666_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1365-2036.2009.04008.x","volume":"30","author":"AC Ford","year":"2009","unstructured":"Ford AC, Ching E, Moayyedi P. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Aliment Pharmacol Ther. 2009;30:28\u201336.","journal-title":"Aliment Pharmacol Ther"},{"key":"4666_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cgh.2012.11.033","volume":"11","author":"A Sainsbury","year":"2012","unstructured":"Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol. 2012;11:359\u2013365e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4666_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MEG.0b013e328342a547","volume":"23","author":"SM Barratt","year":"2011","unstructured":"Barratt SM, Leeds JS, Robinson K, et al. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011;23:159\u2013165.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4666_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","volume":"11","author":"G Oberhuber","year":"1999","unstructured":"Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185\u20131194.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4666_CR8","first-page":"1328-34","volume":"7","author":"DA Leffler","year":"2009","unstructured":"Leffler DA, Dennis M, Edwards George J, et al. A validated disease-specific symptom index for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7:1328-34\u20131334-3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4666_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/apt.13725","volume":"44","author":"JA Silvester","year":"2016","unstructured":"Silvester JA, Graff LA, Rigaux L, Walker JR, Duerksen DR. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther. 2016;44:612\u2013619.","journal-title":"Aliment Pharmacol Ther"},{"key":"4666_CR10","first-page":"530-6","volume":"7","author":"DA Leffler","year":"2009","unstructured":"Leffler DA, Dennis M, Edwards George JB, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7:530-6\u2013536-2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4666_CR11","unstructured":"R Studio Team. RStudio: Integrated Development for R. Boston, MA: RStudio Inc.; 2016. \n                    http:\/\/www.rstudio.com\/\n                    \n                  ."},{"key":"4666_CR12","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing;  2016. \n                    https:\/\/www.R-project.org\/\n                    \n                  ."},{"key":"4666_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1155\/2012\/861478","volume":"26","author":"RN Fedorak","year":"2012","unstructured":"Fedorak RN, Vanner SJ, Paterson WG, Bridges RJ. Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact. Can J Gastroenterol. 2012;26:252\u2013256.","journal-title":"Can J Gastroenterol"},{"key":"4666_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","volume":"64","author":"AC Ford","year":"2015","unstructured":"Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049\u20131057.","journal-title":"Gut"},{"key":"4666_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","volume":"10","author":"RM Lovell","year":"2012","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712\u2013721.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4666_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/gut.2009.202234","volume":"59","author":"JK Marshall","year":"2010","unstructured":"Marshall JK, Thabane M, Garg AX, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59:605\u2013611.","journal-title":"Gut"},{"key":"4666_CR17","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/ajg.2012.260","volume":"107","author":"SJ Halpin","year":"2012","unstructured":"Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1474\u20131482.","journal-title":"Am J Gastroenterol"},{"key":"4666_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1365-2036.2008.03813.x","volume":"28","author":"AC Ford","year":"2008","unstructured":"Ford AC, Forman D, Bailey AG, Axon ATR, Moayyedi P. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther. 2008;28:1013\u20131020.","journal-title":"Aliment Pharmacol Ther"},{"key":"4666_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/S0007114515004183","volume":"115","author":"M Coletta","year":"2016","unstructured":"Coletta M, Gates FK, Marciani L, et al. Effect of bread gluten content on gastrointestinal function: a crossover MRI study on healthy humans. Br J Nutr. 2016;115:55\u201361.","journal-title":"Br J Nutr"},{"key":"4666_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2036.2010.04386.x","volume":"32","author":"D Wild","year":"2010","unstructured":"Wild D, Robins GG, Burley VJ, Howdle PD. Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther. 2010;32:573\u2013581.","journal-title":"Aliment Pharmacol Ther"},{"key":"4666_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10620-014-3436-4","volume":"60","author":"MA Khan","year":"2015","unstructured":"Khan MA, Nusrat S, Khan MI, Nawras A, Bielefeldt K. Low-FODMAP diet for irritable bowel syndrome: is it ready for prime time? Dig Dis Sci. 2015;60:1169\u20131177.","journal-title":"Dig Dis Sci"},{"key":"4666_CR22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/apt.13167","volume":"41","author":"SSC Rao","year":"2015","unstructured":"Rao SSC, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41:1256\u20131270.","journal-title":"Aliment Pharmacol Ther"},{"key":"4666_CR23","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s10620-016-4264-5","volume":"61","author":"E Waszczuk","year":"2016","unstructured":"Waszczuk E, Waszczuk K. Gluten, dysbiosis, and genetics in celiac disease: all are important [Letter to the Editor]. Dig Dis Sci. 2016;61:2761\u20132762.","journal-title":"Dig Dis Sci"},{"key":"4666_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MEG.0b013e328346a56e","volume":"23","author":"MI Vazquez-Roque","year":"2011","unstructured":"Vazquez-Roque MI, Camilleri M, Carlson P, et al. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2011;23:481\u2013487.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4666_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cgh.2015.12.031","volume":"14","author":"I Aziz","year":"2016","unstructured":"Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M, Sanders DS. Efficacy of a gluten-free diet in subjects with irritable bowel syndrome-diarrhea unaware of their HLA-DQ2\/8 genotype. Clin Gastroenterol Hepatol. 2016;14:696\u2013703-e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4666_CR26","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/ajg.2016.439","volume":"111","author":"I Comino","year":"2016","unstructured":"Comino I, Fern\u00e1ndez-Ba\u00f1ares F, Esteve M, et al. Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients. Am J Gastroenterol. 2016;111:1456\u20131465.","journal-title":"Am J Gastroenterol"},{"key":"4666_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MPG.0000000000001270","volume":"64","author":"D Gidrewicz","year":"2017","unstructured":"Gidrewicz D, Trevenen CL, Lyon M, Butzner JD. Normalization time of celiac serology in children on a gluten-free Diet. J Pediatr Gastroenterol Nutr. 2017;64:362\u2013367.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4666-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4666-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4666-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:37:50Z","timestamp":1589726270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4666-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4666"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4666-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,7]]},"assertion":[{"value":"22 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DRD is on speaker\u2019s bureau for Shire Canada. CNB is supported in part by the Bingham Chair in Gastroenterology. He has served on advisory boards of Abbvie Canada, Ferring Canada, Janssen Canada, Shire Canada, Takeda Canada, and Pfizer Canada and as a consultant to Mylan Pharmaceuticals. He has received educational grants from Shire Canada, Abbvie Canada, Takeda Canada, and Janssen Canada and is on the speaker\u2019s bureau for Abbvie Canada, Ferring Canada and Shire Canada. CPK has worked as a consultant for Takeda Pharmaceuticals and Cour Pharmaceuticals. DAL is an employee of Takeda Pharmaceuticals. LAG, LR, JAS, JRW\u2014nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}